Skip to main content
Premium Trial:

Request an Annual Quote

Atossa Inks Deal with PPO for Breast Cancer Tests

NEW YORK (GenomeWeb News) – Atossa Genetics today announced it has entered into a contract with preferred provider organization FedMed, giving its members access to Atossa's breast health tests.

FedMed has more than 550,000 providers in its network, including 4,000 hospitals, and more than 60,000 ancillary facilities. It serves more than 40 million Americans.

Among the tests offered by Seattle-based Atossa, which went public in November, are the ForeCYTE Breast Health Test, a risk stratification test for breast cancer, and the ArgusCYTE Breast Health Test for monitoring patients for the potential recurrence of breast cancer.

The agreement with FedMed will provide patients and doctors greater access to Atossa's tests and help fill "a significant unmet clinical need in the medical community for more effective ways to identify women at high risk of breast cancer," Atossa Chairman, President, and CEO Steven Quay said in a statement.

In September, the company signed a deal with managed healthcare plan MultiPlan giving its providers and patients access to Atossa's tests.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.